Electric mobility, drones, bulk drugs to contribute $170 bn to manufacturing by 2025-26: DIPP working group

NEW DELHI: Biotechnology, electric mobility, unmanned aerial vehicles and bulk drugs are among the eight emerging sectors that will contribute $170 billion to India’s manufacturing gross value added by 2025-26, a working group of the Department of Industrial Policy and Promotion (DIPP) has said.

Medical devices, robotics & automation equipment, advanced materials, and chemicals are the other emerging sectors that the group has identified to play a significant role in manufacturing.

“These sectors have exponential growth potential which need to be explored. Detailed assessment of the potential of these sectors should be taken up and actionable roadmaps drawn up to harness the potential,” said the working group on making India a $5 trillion economy by 2025 in its report.

Focus on emerging sectors is part of the three pronged strategy suggested by the group to achieve $1 trillion from manufacturing. Focus on existing high impact sectors and medium, small and micro enterprises (MSME) are the other two pillars.

Another $1 trillion from is expected to come from agriculture and allied activities while contribution from the services sector is pegged at $3 trillion.

The report has suggested an e-commerce policy and regulatory framework to strengthen the country’s logistics sector and using e-commerce to facilitate access to larger markets both domestic and international.

It said in the defence sector, there is a need to identify key components and systems and encourage global leaders to set up manufacturing base in India by offering limited period incentives; and ensure incentives result in technology/process transfer.

“Where applicable, leverage government purchases (Offset Policy), particularly for technology transfer; and ensure high-quality anchor investors capable of spurring growth of associated suppliers (including MSMEs) and offer limited period incentives to anchors, if required,” it said.

To boost electronics manufacturing, it said the government should consider offering additional fiscal incentives such as a limited-period tax holiday to players investing more than an identified threshold of investment. The report suggested measures to boost manufacturing in other areas including aeronautical, space, garments, organic and ayurvedic products.

Related Posts

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

New Delhi: AstraZeneca’s India-arm has partnered with National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, to build clinical research capabilities at 25 emerging geographies in a bid to extend…

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Following a bumpy regulatory road that involved a refusal-to-file, ImmunityBio has won FDA approval to expand Anktiva into papillary-only non-muscle-invasive bladder cancer (NMIBC). Wednesday’s approval comes nearly three months ahead…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction